Carregant...
Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato‐O, O′)‐diammine Platinum (II) (NSC 375101D)
Thrombocytopenia is the most serious dose‐limiting toxicity of (glycolato‐O, O′)‐diammine platinum (II) (254‐S; NSC 375101D), one of the new platinum analogues. A total of 38 patients treated with 100 mg of 254‐S per m(2) in a clinical phase II study were retrospectively analyzed to determine the fa...
Guardat en:
| Publicat a: | Jpn J Cancer Res |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Blackwell Publishing Ltd
1990
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5963895/ https://ncbi.nlm.nih.gov/pubmed/2110134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1990.tb02548.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|